Congcong Xu

1.8k total citations · 1 hit paper
40 papers, 1.2k citations indexed

About

Congcong Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Congcong Xu has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Congcong Xu's work include RNA Interference and Gene Delivery (13 papers), Advanced biosensing and bioanalysis techniques (13 papers) and MicroRNA in disease regulation (5 papers). Congcong Xu is often cited by papers focused on RNA Interference and Gene Delivery (13 papers), Advanced biosensing and bioanalysis techniques (13 papers) and MicroRNA in disease regulation (5 papers). Congcong Xu collaborates with scholars based in China, United States and Egypt. Congcong Xu's co-authors include Peixuan Guo, Dan Shu, Hongran Yin, Sijin Guo, Zhen Zheng, Zhefeng Li, Bin Guo, Xiaolian Chen, Jianxiong Xu and Xuan Cai and has published in prestigious journals such as Nature, ACS Nano and ACS Applied Materials & Interfaces.

In The Last Decade

Congcong Xu

36 papers receiving 1.2k citations

Hit Papers

Algorithm for optimized mRNA design improves stability an... 2023 2026 2024 2025 2023 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Algorithm for optimized mRNA design improves stability and immunogenicity
    2023 232 citations He Zhang, Liang Zhang et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Congcong Xu China 15 963 233 139 119 107 40 1.2k
Baisong Zheng China 20 501 0.5× 126 0.5× 133 1.0× 118 1.0× 70 0.7× 48 964
Mohammad M. Pourseif Iran 18 621 0.6× 56 0.2× 91 0.7× 159 1.3× 105 1.0× 35 1.1k
Jun Lei China 21 576 0.6× 106 0.5× 65 0.5× 109 0.9× 72 0.7× 76 1.0k
Tongrui Liu United States 14 583 0.6× 237 1.0× 78 0.6× 69 0.6× 28 0.3× 31 1.1k
Yeji Lee South Korea 19 919 1.0× 110 0.5× 151 1.1× 217 1.8× 57 0.5× 73 1.5k
Mohammadreza Sharifi Iran 22 1.2k 1.2× 795 3.4× 78 0.6× 158 1.3× 40 0.4× 98 1.8k
Patricia Galán‐Malo Spain 19 671 0.7× 90 0.4× 170 1.2× 114 1.0× 32 0.3× 37 1.0k

Countries citing papers authored by Congcong Xu

Since Specialization
Citations

This map shows the geographic impact of Congcong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Congcong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Congcong Xu more than expected).

Fields of papers citing papers by Congcong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Congcong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Congcong Xu. The network helps show where Congcong Xu may publish in the future.

Co-authorship network of co-authors of Congcong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Congcong Xu. A scholar is included among the top collaborators of Congcong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Congcong Xu. Congcong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xu, Congcong, Yang Lv, Dekun Liu, & Weichang Gong. (2025). Exploring cellular biological effect of short-term stimulation of different high-intensity static magnetic fields on fresh-cut young ginger based on metabolome analysis. Food Research International. 211. 116423–116423.
3.
4.
Yang, Xiaodan, Congcong Xu, Tianjiao Sun, et al.. (2025). SIRT4 Promotes Pancreatic Cancer Stemness by Enhancing Histone Lactylation and Epigenetic Reprogramming Stimulated by Calcium Signaling. Advanced Science. 12(20). e2412553–e2412553. 3 indexed citations
5.
Shi, Tianyu, et al.. (2025). In vivo nano-engineering T cells for CAR-T therapy. Journal of Controlled Release. 388(Pt 2). 114379–114379.
6.
Qiu, Zhiqiang, et al.. (2024). Predictive role of neutrophil-to-lymphocyte ratio in metabolic syndrome: Meta-analysis of 70,937 individuals. BMC Endocrine Disorders. 24(1). 155–155. 7 indexed citations
7.
Zhang, Kai, et al.. (2023). Knockout of ENO1 leads to metabolism reprogramming and tumor retardation in pancreatic cancer. Frontiers in Oncology. 13. 1119886–1119886. 13 indexed citations
8.
Zhang, He, Liang Zhang, Ang Lin, et al.. (2023). Algorithm for optimized mRNA design improves stability and immunogenicity. Nature. 621(7978). 396–403. 232 indexed citations breakdown →
9.
Peng, Xiaopeng, Zhihao Hu, Congcong Xu, et al.. (2023). Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies. Acta Pharmaceutica Sinica B. 14(2). 533–578. 39 indexed citations
10.
Xu, Congcong, et al.. (2022). Itraconazole Inhibits the Growth of Cutaneous Squamous Cell Carcinoma by Targeting HMGCS1/ACSL4 Axis. Frontiers in Pharmacology. 13. 828983–828983. 16 indexed citations
11.
Guo, Sijin, Hui Li, Kaiming Zhang, et al.. (2021). Regulation of reversible conformational change, size switching, and immunomodulation of RNA nanocubes. RNA. 27(9). 971–980. 4 indexed citations
12.
Xu, Congcong, et al.. (2019). <p>Role of heat shock protein 22 in the protective effect of geranylgeranylacetone in response to oxidized-LDL</p>. Drug Design Development and Therapy. Volume 13. 2619–2632. 7 indexed citations
13.
Yin, Hongran, Gaofeng Xiong, Sijin Guo, et al.. (2019). Delivery of Anti-miRNA for Triple-Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting Stem Cell Marker CD133. Molecular Therapy. 27(7). 1252–1261. 134 indexed citations
14.
Zheng, Zhen, Zhefeng Li, Congcong Xu, Bin Guo, & Peixuan Guo. (2019). Folate-displaying exosome mediated cytosolic delivery of siRNA avoiding endosome trapping. Journal of Controlled Release. 311-312. 43–49. 121 indexed citations
15.
Xu, Congcong, Hui Li, Kaiming Zhang, et al.. (2018). Photo-controlled release of paclitaxel and model drugs from RNA pyramids. Nano Research. 12(1). 41–48. 35 indexed citations
16.
Xu, Congcong, et al.. (2017). Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy. Cancer Letters. 414. 57–70. 62 indexed citations
17.
Haque, Farzin, Congcong Xu, Daniel L. Jasinski, Hui Li, & Peixuan Guo. (2017). Using Planar Phi29 pRNA Three-Way Junction to Control Size and Shape of RNA Nanoparticles for Biodistribution Profiling in Mice. Methods in molecular biology. 1632. 359–380. 4 indexed citations
18.
Zhao, Wenwen, Fang Zhou, Congcong Xu, et al.. (2013). Clinical Significance of Vimentin Expression and Her‐2 Status in Patients with Gastric Carcinoma. Clinical and Translational Science. 6(3). 184–190. 10 indexed citations
19.
Xu, Jianxiong, Congcong Xu, Xiaolian Chen, et al.. (2013). Regulation of an antioxidant blend on intestinal redox status and major microbiota in early weaned piglets. Nutrition. 30(5). 584–589. 112 indexed citations
20.
Yue, Lu, Ying Wang, Huamao Wang, et al.. (2012). Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody. Oncology Reports. 28(4). 1453–1460. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Baisong Zheng Breakdown of academic impact, for papers by Mohammad M. Pourseif Breakdown of academic impact, for papers by Jun Lei Breakdown of academic impact, for papers by Tongrui Liu Breakdown of academic impact, for papers by Yeji Lee Breakdown of academic impact, for papers by Mohammadreza Sharifi Breakdown of academic impact, for papers by Patricia Galán‐Malo
Rankless by CCL
2026